NFE2L2 and hepatocellular carcinoma: Knocking down NRF2 in A549 lung adenocarcinoma cells and in sulforaphane-treated (10 μM) BEAS-2B bronchial epithelial cells and HepG2 hepatocellular carcinoma cells showed decreased AMBP transcript levels (14).